Treatment
Treatment A clinical trials
We’re tracking 8,310 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT06605079Recruiting
Palliative care support for ICU patients and families
This trial tests whether adding a specialized palliative care team to the ICU can help patients, families, and staff. You or your relative may be eligible if the ICU doctor sees a need for extra support, such as when there is disagreement about treatment or when therapy limits are being considered.
PragueAges 18 years+ - NCT06613854RecruitingPhase 4
Early combination therapy for type 2 diabetes
This study tests if starting two newer diabetes drugs (empagliflozin and semaglutide) soon after diagnosis, along with metformin, helps control blood sugar better than metformin alone. It's for people diagnosed with type 2 diabetes in the last two years who are already taking a high dose of metformin.
LjubljanaAges 18–70 - NCT06609330Recruiting
Anger and aggression help after military betrayal
This study offers a program to help people who feel angry and have acted aggressively after a betrayal during military service. It aims to reduce anger and aggression so you can feel better and improve your relationships.
Fort Cavazos, TexasAges 18 years+ - NCT06610565Recruiting
Fasting-mimicking diet for breast cancer side effects
This study tests if a special diet that mimics fasting can help reduce side effects from hormone therapy (aromatase inhibitors) in women with breast cancer. The diet is a low-calorie meal plan designed to lower cholesterol and improve well-being.
Milan, ItalyAges 18 years+ - NCT06603662RecruitingPhase 4
Steroids for sudden osteoarthritis pain in the emergency room
This trial tests if a short course of oral steroids (glucocorticoids) can relieve sudden osteoarthritis pain in the knee, hip, or shoulder for people who come to the emergency department and are well enough to go home.
York, PennsylvaniaAges 18 years+ - NCT06610240Enrolling by invitation
Treatment outcomes for early-stage lung cancer after pre-surgery therapy
This trial looks at how well different treatments work before surgery for early-stage non-small cell lung cancer (NSCLC). It aims to help doctors understand which pre-surgery therapies lead to the best outcomes.
Shanghai, Shanghai MunicipalityAges Any age - NCT06615908RecruitingPhase 1
Psilocybin therapy for lingering concussion symptoms
This study tests whether a single dose of psilocybin, given with therapist support, can reduce long-lasting symptoms after a concussion. If your symptoms have continued for months, you may be eligible.
Calgary, AlbertaAges 18–65 - NCT06611878Recruiting
Music training for Alzheimer's patients at home
This trial tests whether intensive music training can help memory in people with Alzheimer's disease who live at home and are not musicians.
Buenos AiresAges 65 years+ - NCT06610734RecruitingPhase 2
Combination treatment for extensive-stage small cell lung cancer
This study tests a new combination treatment for extensive-stage small cell lung cancer. You would receive an immunotherapy drug (adebrelimab) together with chemotherapy and a very low dose of chest radiation, to see if this helps control the cancer better.
SichuanAges 18–75 - NCT06609265Recruiting
Shockwave therapy for stress fractures in the lower body
This study tests whether shockwave therapy (a non-surgical treatment using sound waves) can help heal stress fractures or bone stress injuries in the lower body (pelvis, hip, thigh, shin, heel, or foot). It may help you recover faster and avoid surgery.
Los Angeles, CaliforniaAges 18–50 - NCT06605833Enrolling by invitation
Heart health after immunotherapy for melanoma
This study looks at heart health in people who have finished immunotherapy for melanoma. It uses MRI scans to check for any heart problems that may have developed after treatment.
LondonAges 18 years+ - NCT06617182RecruitingPhase 2
Thalidomide and glutamine for radiation bowel injury
This trial tests whether combining thalidomide and glutamine helps people with bleeding caused by past radiation treatment to the abdomen or pelvis. The medication may reduce inflammation and help healing.
Xi'an, ShaanxiAges 18–80 - NCT06606028Recruiting
Blood test for leftover cancer DNA after head and neck cancer treatment
This study uses a simple blood test to look for leftover cancer DNA after treatment for head and neck squamous cell carcinoma. The goal is to see if the test can find very small amounts of cancer early, which might help doctors make better decisions about follow-up care.
San Francisco, CaliforniaAges 18 years+ - NCT06609980RecruitingPhase 1
Fecal transplant to restore gut health in infants
This study tests whether giving a baby’s own stool back to them (after it was stored before antibiotics) can help restore healthy gut bacteria. It’s for healthy infants and toddlers up to 4 years old who haven’t recently taken antibiotics.
New Brunswick, New JerseyAges 1 month–4 years - NCT06614868Recruiting
Stress counseling for LGBTQ+ individuals
This study tests a counseling program designed to help LGBTQ+ people cope with stress related to their identity. It may help you if you're looking for support dealing with the unique challenges of being a sexual minority.
Birmingham, AlabamaAges 18 years+ - NCT06616155RecruitingPhase 1/Phase 2
Ruxolitinib and Enzalutamide for Resistant Prostate Cancer
This trial tests two drugs—ruxolitinib and enzalutamide—together to see if they can help men whose prostate cancer has spread and stopped responding to abiraterone. It is for those whose cancer grew quickly on abiraterone.
Chicago, IllinoisAges 18 years+ - NCT06612229Recruiting
Bile leaks after surgery for liver echinococcosis
This study looks at how bile leaks (fistulas) happen after surgery for liver echinococcosis, a parasitic infection. It aims to improve understanding and treatment to help patients recover better.
TashkentAges 18 years+ - NCT06617858RecruitingPhase 2
AMB-05X for colorectal cancer with ctDNA after treatment
This trial tests a drug called AMB-05X for people with colorectal cancer who have completed all intended treatments and show no signs of cancer on scans, but still have cancer DNA (ctDNA) in their blood. The goal is to see if AMB-05X can eliminate this remaining cancer DNA and prevent the cancer from coming back.
Houston, TexasAges 18 years+ - NCT06600802Recruiting
Lu-PSMA treatment for advanced prostate cancer
This study tests a radioactive drug called Lu-PSMA-617 for men with advanced prostate cancer that has spread and is no longer responding to hormone therapy. The drug targets a protein on cancer cells to deliver radiation directly to the tumor.
Clermont-FerrandAges 18 years+ - NCT06611007RecruitingPhase 1/Phase 2
Lipiodol injections for painful finger arthritis not helped by usual treatments
This trial tests if injecting a special dye (Lipiodol) into the blood vessels of the fingers can safely reduce pain and symptoms in people with hand osteoarthritis that hasn't responded to standard pain relievers.
ÉchirollesAges 40 years+ - NCT06611839RecruitingPhase 1/Phase 2
Combination therapy for IDH1-mutated AML
This trial tests a combination of three drugs (venetoclax, ivosidenib, and azacitidine) for people newly diagnosed with a specific type of AML that has an IDH1 mutation. The goal is to see if this mix works better than standard treatments.
Tianjin, Tianjin MunicipalityAges 14 years+ - NCT06608277RecruitingPhase 2
Ketamine and nerve block for headache or PTSD after brain injury
This study tests if ketamine infusions or a stellate ganglion block (a numbing injection near the neck) can help people with long-term headaches or PTSD after a traumatic brain injury. It compares these treatments alone and together.
Chicago, IllinoisAges 18 years+ - NCT06607523Recruiting
Prebiotic treatment for brain injury recovery
This study tests whether a prebiotic (a type of fiber that feeds healthy gut bacteria) can improve recovery from a brain injury by helping the connection between the gut and the brain. Participants include people with a recent brain injury and their family members or staff, all of whom are part of the Moody Neurorehabilitation Institute community.
Galveston, TexasAges 18 years+ - NCT06182436Recruiting
Virtual reality for pain during eczema injection
This trial tests whether playing a virtual reality game during a dupilumab injection (for eczema) can help reduce pain and anxiety. It's for kids and teens aged 6 to 17 who are already taking or about to start this medicine.
Montreal, QuebecAges 6–17
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,310 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.